share_log

New Journey Health Technology GroupLTD's (SZSE:002219) Anemic Earnings Might Be Worse Than You Think

New Journey Health Technology GroupLTD's (SZSE:002219) Anemic Earnings Might Be Worse Than You Think

New Journey Health Technology GroupLtd(深圳證券交易所:002219)的收入疲軟可能比你想象的還要糟糕
Simply Wall St ·  04/25 19:17

The subdued market reaction suggests that New Journey Health Technology Group Co.,LTD's (SZSE:002219) recent earnings didn't contain any surprises. However, we believe that investors should be aware of some underlying factors which may be of concern.

疲軟的市場反應表明,新徵程健康科技集團有限公司,LTD(深圳證券交易所:002219)最近的業績沒有任何意外。但是,我們認爲,投資者應注意一些可能令人擔憂的潛在因素。

earnings-and-revenue-history
SZSE:002219 Earnings and Revenue History April 25th 2024
SZSE:002219 收益和收入歷史記錄 2024 年 4 月 25 日

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

Importantly, our data indicates that New Journey Health Technology GroupLTD's profit was reduced by CN¥20m, due to unusual items, over the last year. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect New Journey Health Technology GroupLTD to produce a higher profit next year, all else being equal.

重要的是,我們的數據表明,由於異常項目,新徵程健康科技集團有限公司的利潤比去年減少了2000萬元人民幣。儘管由於不尋常項目而產生的扣除首先令人失望,但有一線希望。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。而且,畢竟,這正是會計術語的含義。假設這些不尋常的支出不會再次出現,因此,我們預計新徵程健康科技集團有限公司在其他條件相同的情況下,明年將實現更高的利潤。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of New Journey Health Technology GroupLTD.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對新徵程健康科技集團有限公司的資產負債表分析。

An Unusual Tax Situation

不尋常的稅收狀況

Having already discussed the impact of the unusual items, we should also note that New Journey Health Technology GroupLTD received a tax benefit of CN¥29m. This is of course a bit out of the ordinary, given it is more common for companies to be paying tax than receiving tax benefits! The receipt of a tax benefit is obviously a good thing, on its own. However, our data indicates that tax benefits can temporarily boost statutory profit in the year it is booked, but subsequently profit may fall back. In the likely event the tax benefit is not repeated, we'd expect to see its statutory profit levels drop, at least in the absence of strong growth.

在已經討論了這些不尋常物品的影響之後,我們還應該指出,新徵程健康科技集團有限公司獲得了2900萬元人民幣的稅收優惠。這當然有點不尋常,因爲公司納稅比獲得稅收優惠更爲普遍!獲得稅收優惠本身顯然是一件好事。但是,我們的數據表明,稅收優惠可以暫時增加賬面當年的法定利潤,但隨後利潤可能會回落。如果稅收優惠可能不重演,我們預計其法定利潤水平將下降,至少在沒有強勁增長的情況下是如此。

Our Take On New Journey Health Technology GroupLTD's Profit Performance

我們對新徵程健康科技集團有限公司盈利表現的看法

In its last report New Journey Health Technology GroupLTD received a tax benefit which might make its profit look better than it really is on a underlying level. But on the other hand, it also saw an unusual item depress its profit. Given the contrasting considerations, we don't have a strong view as to whether New Journey Health Technology GroupLTD's profits are an apt reflection of its underlying potential for profit. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. When we did our research, we found 3 warning signs for New Journey Health Technology GroupLTD (1 doesn't sit too well with us!) that we believe deserve your full attention.

在上一份報告中,New Journey Health Technology GroupLtd獲得了稅收優惠,這可能會使其利潤看起來比實際水平要好。但另一方面,它也看到一件不尋常的物品抑制了其利潤。鑑於截然不同的考慮,我們對新徵程健康科技集團有限公司的利潤是否恰當地反映了其潛在的盈利潛力沒有強烈的看法。因此,如果你想更深入地研究這隻股票,那麼考慮它面臨的任何風險至關重要。當我們進行研究時,我們發現了 New Journey Health Technology GroupLtd 的 3 個警告信號(1 個對我們來說不太合適!)我們認爲值得你全神貫注。

In this article we've looked at a number of factors that can impair the utility of profit numbers, as a guide to a business. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

在這篇文章中,我們研究了許多可能損害利潤數字效用的因素,以此作爲企業的指南。但是,還有很多其他方法可以讓你對公司的看法。有些人認爲高股本回報率是優質業務的好兆頭。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論